Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis-Reference-Cited by-同舟云学术

Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis

Published:2005 Issue:10 Volume:52 Page:3058-3062
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Verpoort Kirsten N.,van Gaalen Floris A.,van der Helm-van Mil Annette H. M.,Schreuder Geziena M. T.,Breedveld Ferdinand C.,Huizinga Tom W. J.,de Vries Rene R. P.,Toes Rene E. M.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference22 articles.

1. The contribution of H LA to rheumatoid arthritis

2. The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

3. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study

4. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

5. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Phenotypes, Serological Biomarkers, and Synovial Features Defining Seropositive and Seronegative Rheumatoid Arthritis: A Literature Review;Cells;2024-04-24

2. Type 17-specific immune pathways are active in early spondyloarthritis;RMD Open;2023-12

3. Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association;RMD Open;2023-12

4. Type 17 specific immune pathways are active in early spondyloarthritis;2022-12-21

5. ACPA-negative rheumatoid arthritis: From immune mechanisms to clinical translation;eBioMedicine;2022-09